Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Urinary Kallidinogenase in Acute Ischemic Stroke
NCT04102956Phase 4Completed
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jul 2017
- Primary completion
- Mar 2019
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Human urinary kallidinogenase in ischemic stroke, sponsored by The Second Hospital of Hebei Medical University. Started Jul 2017; status: completed.
02
Drugs
Human urinary kallidinogenase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04102956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102956.